About Teduglutide
Class: | Glucagon-like peptide-2 (GLP-2) analog
Use: | Treatment of short bowel syndrome (SBS) in patients who are dependent on parenteral support
Adult dose: | 0.05 mg/kg subcutaneously once daily, with a maximum dose of 1.25 mg per day
Pediatric dose: | Safety and efficacy not established in pediatric patients
Side effects: | Abdominal pain, nausea, headache, injection site reactions, and diarrhea
Contraindications: | Known hypersensitivity to teduglutide or any of its components; hi
Drug Class
Glucagon-like peptide-2 (GLP-2) analog
Uses & Indications
Treatment of short bowel syndrome (SBS) in patients who are dependent on parenteral support
Storage Requirements
Store in the refrigerator (2°C to 8°C or 36°F to 46°F); do not freeze; protect from light
Manufacturer & Packaging
Manufacturer: Takeda Pharmaceuticals International AG , Ireland
Package Size
28’s vial
Price & Supplier
Price in UAE: AED 43681.05
Dosage Information
Adult Dose
0.05 mg/kg subcutaneously once daily, with a maximum dose of 1.25 mg per day
Pediatric Dose
Safety and efficacy not established in pediatric patients
Side Effects
Abdominal pain, nausea, headache, injection site reactions, and diarrhea
Contraindications & Precautions
Known hypersensitivity to teduglutide or any of its components; history of gastrointestinal obstruction
Important Warnings
Risk of intestinal obstruction; monitor for signs of bowel obstruction; may increase risk of neoplasms; not recommended for use in patients with active malignancy
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.